Lopinavir
ATC J05AR · 10 markets · 50 records
US 9 records · 3 strengths
GB 7 records · 4 strengths
AU 5 records · 4 strengths
- 200 mgtabletKaletraKALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle
- 400 mg/5 mLliquidKaletra
- 80 mg/mLliquidKALETRA oral solution bottle
Records without a stated strength · 1 Kaletra
HK 5 records · 1 strengths
Records without a stated strength · 1 Kaletra、LOPINAVIR AND RITONAVIR TABLETS USP 100MG/25MG
CA 3 records · 3 strengths
ES 3 records · 3 strengths
- 200 mgtabletKaletra
- 100 mgtabletKaletra
- 400 mgliquidKALETRA MG)/ML
SG 2 records · 2 strengths
CN 2 records · 1 strengths
- 200 mgtablet克力芝洛匹那韦Manufacturer: 安徽贝克生物制药有限公司
MX 2 records · 1 strengths
Records without a stated strength · 1 DALOVIA、GADANME
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Kaletra、LOPINAVIR/RITONAVIR VIATRIS
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 200 mg tablet | Manufacturer: Camber Pharmaceuticals, Inc. ×2 Manufacturer: Laurus Labs Limited ×2 Manufacturer: Macleods Pharmaceuticals Li… ×2+1Kaletra | Manufacturer: A A H Pharmaceuticals Ltd Manufacturer: Accord-UK Ltd Manufacturer: Viatris UK Healthcare Ltd+1Kaletra | Kaletra | Kaletra KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottle | Kaletra | Manufacturer: 安徽贝克生物制药有限公司 克力芝洛匹那韦 | Kaletra | |||
| 100 mg tablet | Manufacturer: Camber Pharmaceuticals, Inc. ×2 Manufacturer: Laurus Labs Limited ×2 Manufacturer: Macleods Pharmaceuticals Li… ×2+1Kaletra | Kaletra | Kaletra | Kaletra | ||||||
| 400 mg/5 mL liquid | Kaletra | Kaletra | ||||||||
| 80 mg liquid | Kaletra | Kaletra | ||||||||
| 133.3 mg capsule | Kaletra | |||||||||
| 400 mg liquid | KALETRA MG)/ML | |||||||||
| 80 mg/1 mL liquid | Kaletra | |||||||||
| 80 mg/mL liquid | KALETRA oral solution bottle | |||||||||
unknown | Kaletra | Kaletra LOPINAVIR AND RITONAVIR TABLETS USP 100MG/25MG | Kaletra LOPINAVIR/RITONAVIR VIATRIS | |||||||
tablet | DALOVIA GADANME |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · ES · MX and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · ES · MX que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · ES · MX 有记录（未在本表显示）。 另有 3 個規格/劑型僅在 CA · ES · MX 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.